Skip to content

Monosodium Glutamate on Gastric Emptying

Effect of a Single Dose of Monosodium Glutamate on Delayed Gastric Emptying in Children

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02745028
Enrollment
0
Registered
2016-04-20
Start date
2016-04-30
Completion date
2017-10-31
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Gastric Emptying

Keywords

delayed gastric emptying, children, monosodium glutamate

Brief summary

Children with a radionuclide gastric emptying test with abnormal results will undergo a second test with the addition of a weight adjusted dose of monosodium glutamate. The purpose of the study is to determine if a single dose of monosodium glutamate can shorten the gastric emptying time.

Detailed description

There is evidence that monosodium glutamate has effects on synapsis at the gastric and duodenum level that results in stimulation of contractility resulting on increase rate of gastric emptying. The purpose of the study is to demonstrate that the administration of a single dose of monosodium glutamate can shorten the gastric emptying time. Patients with a prior study indicating a delay of gastric empting time, will undergo a second test with the addition of a weight adjusted dose of monosodium glutamate. Each patient will serve as her/his own control. Results will be analysed by pair-T test.

Interventions

DIETARY_SUPPLEMENTMonosodium glutamate

A single dose of weight adjusted monosodium glutamate will be added at the time of a repeat radionuclide gastric emptying study

Sponsors

International Glutamate Technical Committee
CollaboratorUNKNOWN
Veronica Beatriz Busoni
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Months to 17 Years
Healthy volunteers
No

Inclusion criteria

* children with delayed gastric emptying not receiving prokinetic medication in the last 72 hours

Exclusion criteria

* Prior gastrointestinal surgery, patients with known history of reaction to monosodium glutamate. History of neoplasia, autoimmune or inflammatory bowel disease.

Design outcomes

Primary

MeasureTime frameDescription
Reduced gastric emptying timeDuring the test (4 hours from intake)Percentage of reduction of gastric emptying time when glutamate is administered compared to baseline

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026